Efficacy of Oral Ibodutant in IBS-D Female Patients Measured by Abdominal Pain Severity - An Iris 2 Post-Hoc Analysis

被引：0
|
作者：
Tack, Jan F.
Scartoni, Simona
Tonini, Giulia
Schumacher, Kai
Ott, Kerstin
Koch, Ines
Otranto, Isabella
Bertolotti, Monica
Capriati, Angela
Maggi, Carlo A.
机构：
来源：
GASTROENTEROLOGY | 2015年 / 148卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1377
引用
收藏
页码：S491 / S491
页数：1
相关论文
共 50 条
  • [1] Effects of treatment with eluxadoline on abdominal pain in patients with IBS-D: Additional post hoc analyses of Phase 3 trials
    Lembo, Anthony J.
    Covington, Paul S.
    Dove, Leonard S.
    Andrae, David A.
    [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2020, 32 (04):
  • [2] Characterization of Abdominal Pain Response to Rifaximin in Patients with Irritable Bowel Syndrome with Diarrhea (IBS-D), by Baseline Pain Severity
    Lembo, Anthony
    Heimanson, Zeev
    Cash, Brooks D.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S251 - S251
  • [3] CHARACTERIZATION OF ABDOMINAL PAIN RESPONSE TO RIFAXIMIN IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D), BY BASELINE PAIN SEVERITY
    Lembo, Anthony
    Heimanson, Zeev
    Cash, Brooks D.
    [J]. GASTROENTEROLOGY, 2019, 156 (06) : S775 - S775
  • [4] Characterization of abdominal pain response to rifaximin in patients with irritable bowel syndrome with diarrhea (IBS-D), by baseline (BL) pain severity
    Lembo, A.
    Heimanson, Z.
    Cash, B. D.
    [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2019, 31
  • [5] Assessment of IBS-D Severity: A Case Study From Two Randomized, Double-Blind, Placebo-Controlled Pivotal Trials to Evaluate the Efficacy of Oral Ibodutant
    Tack, Jan F.
    Scartoni, Simona
    Tonini, Giulia
    Schumacher, Kai
    Bertolotti, Monica
    Nuti, Alessandra
    Ott, Kerstin
    Cera, Grazia Simona
    Capriati, Angela
    Maggi, Carlo A.
    [J]. GASTROENTEROLOGY, 2015, 148 (04) : S490 - S491
  • [6] THE LOW FODMAP DIET IS EQUALLY EFFICACIOUS IN IBS-D PATIENTS WITH AND WITHOUT BASELINE ANXIETY: A POST-HOC ANALYSIS FROM A US RANDOMIZED, CONTROLLED TRIAL
    Eswaran, Shanti L.
    Chey, William D.
    Jackson, Kenya
    Han-Markey, Theresa
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S719 - S719
  • [7] Linaclotide Improves Abdominal Symptoms Regardless of Baseline IBS Symptom Severity: A Post-Hoc Analysis of a Phase 3b Trial
    Sayuk, Gregory S.
    Chang, Lin
    Bartolini, Wilmin
    Li, Ella
    Fox, Susan
    Shea, Elizabeth
    Boinpally, Ramesh
    Bochenek, Wieslaw
    Borgstein, Niels
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S235 - S236
  • [8] Assessing the Efficacy of Rifaximin in Diarrhea-Predominant Irritable Syndrome (IBS-D): A Post hoc Analysis of 2 Phase 3, Randomized, Placebo-Controlled Trials
    Pimentel, Mark
    Cash, Brooks D.
    Lacy, Brian E.
    Heimanson, Zeev
    Lembo, Anthony J.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S254 - S254
  • [9] Disability or Restriction of Daily Activities is the Most Common Indicator of Disease Severity in Female Patients with Severe IBS-D: An Analysis of the Alosetron Patient Survey
    Nicandro, Jean Paul
    Tennis, Pat
    Bennett, Lee
    Hollis, Kelly
    Shin, Paul
    Chuang, Emil
    Andrews, Elizabeth
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S410 - S410
  • [10] Efficacy of Dulaglutide as a First Injectable Option for Patients with Type 2 Diabetes: A Post-Hoc Pooled Analysis
    Hiren Patel
    Kashif Munir
    Sindee Sutherland
    Chrisanthi A. Karanikas
    Manige Konig
    [J]. Diabetes Therapy, 2019, 10 : 2321 - 2330
12345